Research foundation · First program launches 2026
Medicine that lasts.Prevention thateveryone can afford.
The World Peace & Prosperity Foundation is a youth-founded research foundation combining AI and drug discovery to build long-lasting, affordable preventive solutions for allergies, eczema, and other immune-driven disease.
- research programs
- 3
- research programs
- first program launch
- 2026
- first program launch
- pipeline & findings
- Open
- pipeline & findings
The problem
Immune-driven disease is common, chronic, and expensive to live with.
Allergies and eczema touch a third of American households. Care is mostly symptomatic, repeated monthly, and priced for those who can afford it. The pipeline that could change that takes a decade and billions of dollars per drug.
1 in 3
U.S. adults reported a seasonal allergy, eczema, or food allergy in 2021
Source: CDC / NCHS Data Brief No. 460 (2023)1 in 4
U.S. children reported a seasonal allergy, eczema, or food allergy in 2021
Source: CDC / NCHS Data Brief No. 459 (2023)$2.6B
estimated capitalized cost to bring one new drug to approval
Source: DiMasi, Grabowski & Hansen, J. Health Econ. (2016)Our approach
AI finds the candidates faster. We insist they be durable and affordable before anything else.
Prevent, don't just treat
Most immune-driven disease is managed symptom by symptom, year after year. We study the upstream drivers so care can start before the flare, not after.
Long-lasting by design
A solution that must be re-bought every month is a subscription, not a cure. We prioritize durable interventions: longer protection from fewer doses.
Affordable from day one
AI-guided discovery can cut years and hundreds of millions from the path to a candidate. We pass that efficiency on, so what we find can reach every family.
Research programs
Three programs, one open pipeline.
AI-Guided Target Discovery
Using machine learning over public immunology datasets to prioritize targets and candidate molecules for allergic and inflammatory disease, before a single wet-lab dollar is spent.
Program details →Durable, Affordable Therapeutics
Partnering with academic labs to move the strongest candidates toward long-acting, low-cost formulations designed for global access.
Program details →Community Health Data
Short, consented surveys and volunteer cohorts that capture how allergies and eczema actually show up in daily life, feeding real-world signal back into discovery.
Program details →Founders
A new generation is building the next medicine.
WPPF was founded by two brothers who saw, from hospital corridors and community kitchens, that prevention is a privilege it should not be. They are students. They are also already a track record.
Meet the founders →Roadmap
From first dataset to first candidate.
Foundation year
- Launch Program P-01: AI-guided target discovery over public immunology datasets.
- Pilot Program P-03: community health surveys with the first volunteer cohort.
- Complete 501(c)(3) determination and publish governance documents.
First results
- Publish the open discovery pipeline and first ranked target list.
- Sign the first academic lab collaboration under Program P-02.
- Release aggregate findings from the community cohort back to participants.
Toward durable, affordable candidates
- Advance one or more candidates into preclinical work with partner labs.
- Expand community cohorts beyond the United States.
- Establish an access-first licensing framework for anything the foundation helps discover.
Founding Partners · 2026
Fund the first year. Be named for all of them.
We are assembling the founding partners who will underwrite the 2026 program. Pledge now; giving instructions follow once our 501(c)(3) determination is issued.